U.S. flag

An official website of the United States government

NM_001048174.2(MUTYH):c.13C>G (p.Arg5Gly) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 6, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003168772.2

Allele description [Variation Report for NM_001048174.2(MUTYH):c.13C>G (p.Arg5Gly)]

NM_001048174.2(MUTYH):c.13C>G (p.Arg5Gly)

Gene:
MUTYH:mutY DNA glycosylase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.1
Genomic location:
Preferred name:
NM_001048174.2(MUTYH):c.13C>G (p.Arg5Gly)
HGVS:
  • NC_000001.11:g.45334493G>C
  • NG_008189.1:g.10978C>G
  • NM_001048171.2:c.13C>G
  • NM_001048172.2:c.13C>G
  • NM_001048173.2:c.13C>G
  • NM_001048174.2:c.13C>GMANE SELECT
  • NM_001128425.2:c.55C>G
  • NM_001293190.2:c.55C>G
  • NM_001293191.2:c.13C>G
  • NM_001293192.2:c.-200C>G
  • NM_001293195.2:c.13C>G
  • NM_001293196.2:c.-200C>G
  • NM_001350650.2:c.-259C>G
  • NM_001350651.2:c.-195C>G
  • NM_012222.3:c.55C>G
  • NP_001041636.2:p.Arg5Gly
  • NP_001041637.1:p.Arg5Gly
  • NP_001041638.1:p.Arg5Gly
  • NP_001041639.1:p.Arg5Gly
  • NP_001121897.1:p.Arg19Gly
  • NP_001121897.1:p.Arg19Gly
  • NP_001280119.1:p.Arg19Gly
  • NP_001280120.1:p.Arg5Gly
  • NP_001280124.1:p.Arg5Gly
  • NP_036354.1:p.Arg19Gly
  • LRG_220t1:c.55C>G
  • LRG_220:g.10978C>G
  • LRG_220p1:p.Arg19Gly
  • NC_000001.10:g.45800165G>C
  • NM_001128425.1:c.55C>G
  • NR_146882.2:n.241C>G
  • NR_146883.2:n.164C>G
Protein change:
R19G
Links:
dbSNP: rs587780088
NCBI 1000 Genomes Browser:
rs587780088
Molecular consequence:
  • NM_001293192.2:c.-200C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001293196.2:c.-200C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001350650.2:c.-259C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001350651.2:c.-195C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001048171.2:c.13C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048172.2:c.13C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048173.2:c.13C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048174.2:c.13C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001128425.2:c.55C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293190.2:c.55C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293191.2:c.13C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293195.2:c.13C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012222.3:c.55C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_146882.2:n.241C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_146883.2:n.164C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003909398Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Mar 6, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps.

Guarinos C, Juárez M, Egoavil C, Rodríguez-Soler M, Pérez-Carbonell L, Salas R, Cubiella J, Rodríguez-Moranta F, de-Castro L, Bujanda L, Serradesanferm A, Nicolás-Pérez D, Herráiz M, Fernández-Bañares F, Herreros-de-Tejada A, Aguirre E, Balmaña J, Rincón ML, Pizarro A, Polo-Ortiz F, Castillejo A, Alenda C, et al.

Clin Cancer Res. 2014 Mar 1;20(5):1158-68. doi: 10.1158/1078-0432.CCR-13-1490. Epub 2014 Jan 27.

PubMed [citation]
PMID:
24470512

Details of each submission

From Ambry Genetics, SCV003909398.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.R19G variant (also known as c.55C>G), located in coding exon 2 of the MUTYH gene, results from a C to G substitution at nucleotide position 55. The arginine at codon 19 is replaced by glycine, an amino acid with dissimilar properties. This alteration was identified in an individual with at least ten colorectal polyps (Guarinos C et al. Clin Cancer Res, 2014 Mar;20:1158-68). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024